{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:38:56Z","timestamp":1788388736204,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Groningen (UMCG)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11307-016-1028-8","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T20:33:41Z","timestamp":1480365221000},"page":"570-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["N-[11C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs"],"prefix":"10.1007","volume":"19","author":[{"given":"S. V.","family":"Hartimath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Khayum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van Waarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A. J. O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. F. J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"1028_CR1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2005-04-1417","volume":"106","author":"T Lapidot","year":"2005","unstructured":"Lapidot T, Dar A, Kollet O (2005) How do stem cells find their way home? Blood 106:1901\u20131910","journal-title":"Blood"},{"key":"1028_CR2","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.95.16.9448","volume":"95","author":"Q Ma","year":"1998","unstructured":"Ma Q (1998) Impaired B-lymphopoiesis, myelopoiesis and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95:9448\u20139453","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1028_CR3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2407-9-176","volume":"9","author":"Z Xiang","year":"2009","unstructured":"Xiang Z, Zeng Z, Tang Z et al (2009) Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer 9:176","journal-title":"BMC Cancer"},{"key":"1028_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","volume":"14","author":"B Fran","year":"2004","unstructured":"Fran B (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171\u2013179","journal-title":"Semin Cancer Biol"},{"key":"1028_CR5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","volume":"107","author":"JA Burger","year":"2005","unstructured":"Burger JA, Kipps TJ (2005) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761\u20131767","journal-title":"Blood"},{"key":"1028_CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1349-7006.2005.00059.x","volume":"96","author":"T Tanaka","year":"2005","unstructured":"Tanaka T, Bai Z, Srinoulprasert Y et al (2005) Chemokines in tumor progression and metastasis. Cancer Sci 96:317\u2013322","journal-title":"Cancer Sci"},{"key":"1028_CR7","first-page":"102","volume":"6","author":"SA Rempel","year":"2000","unstructured":"Rempel SA, Dudas S, Ge S, Gutierrez JA (2000) Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6:102\u2013111","journal-title":"Clin Cancer Res"},{"key":"1028_CR8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2006.02.036","volume":"103","author":"Y Jiang","year":"2006","unstructured":"Jiang Y, Wu X, Shi B et al (2006) Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103:226\u2013233","journal-title":"Gynecol Oncol"},{"key":"1028_CR9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.critrevonc.2010.07.006","volume":"79","author":"UM Domanska","year":"2011","unstructured":"Domanska UM, Kruizinga RC, den Dunnen WFA et al (2011) The chemokine network, a newly discovered target in high grade gliomas. Crit Rev Oncol 79:154\u2013163","journal-title":"Crit Rev Oncol"},{"key":"1028_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrd3320","volume":"10","author":"R Lappano","year":"2011","unstructured":"Lappano R, Maggiolini M (2011) G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 10:47\u201360","journal-title":"Nat Rev Drug Discov"},{"key":"1028_CR11","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","volume":"113","author":"AK Azab","year":"2009","unstructured":"Azab AK, Runnels JM, Pitsillides C et al (2009) CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 113:4341\u20134351","journal-title":"Blood"},{"key":"1028_CR12","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1021\/mp500398r","volume":"11","author":"SV Hartimath","year":"2014","unstructured":"Hartimath SV, van Waarde A, Dierckx RAJO, de Vries EFJ (2014) Evaluation of N-[11C] methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model. Mol Pharm 11:3810\u20133817","journal-title":"Mol Pharm"},{"key":"1028_CR13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nucmedbio.2013.02.003","volume":"40","author":"SV Hartimath","year":"2013","unstructured":"Hartimath SV, Domanska UM, Walenkamp AME et al (2013) [99m Tc] O 2-AMD3100 as a SPECT tracer for CXCR4 receptor imaging. Nucl Med Biol 40:507\u2013517","journal-title":"Nucl Med Biol"},{"key":"1028_CR14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.bmc.2009.01.014","volume":"17","author":"O Jacobson","year":"2009","unstructured":"Jacobson O, Weiss ID, Szajek L et al (2009) 64Cu-AMD3100\u2014a novel imaging agent for targeting chemokine receptor CXCR4. Bioorg Med Chem 17:1486\u20131493","journal-title":"Bioorg Med Chem"},{"key":"1028_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12149-007-0063-6","volume":"21","author":"Y Kimura","year":"2007","unstructured":"Kimura Y, Naganawa M, Sakata M et al (2007) Distribution volume as an alternative to the binding potential for sigma1 receptor imaging. Ann Nucl Med 21:533\u2013535","journal-title":"Ann Nucl Med"},{"key":"1028_CR16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/jcbfm.1994.131","volume":"14","author":"M Laruelle","year":"1994","unstructured":"Laruelle M, Wallace E, Seibyl JP et al (1994) Graphical, kinetic, and equilibrium analyses of in vivo [123I] \u03b2-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 14:982\u2013994","journal-title":"J Cereb Blood Flow Metab"},{"key":"1028_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10585-012-9518-9","volume":"30","author":"D Uchida","year":"2013","unstructured":"Uchida D, Kuribayashi N, Kinouchi M et al (2013) Expression and function of CXCR4 in human salivary gland cancers. Clin Exp Metastasis 30:133\u2013142","journal-title":"Clin Exp Metastasis"},{"key":"1028_CR18","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","volume":"44","author":"CW Hendrix","year":"2000","unstructured":"Hendrix CW, Flexner C, MacFarland RT et al (2000) Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 44:1667\u20131673","journal-title":"Antimicrob Agents Chemother"},{"key":"1028_CR19","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2967\/jnumed.108.053215","volume":"49","author":"SJ Kim","year":"2008","unstructured":"Kim SJ, Lee JS, Im KC et al (2008) Kinetic modeling of 39-deoxy-39-18F-Fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. J Nucl Med 49:2057\u20132066","journal-title":"J Nucl Med"},{"key":"1028_CR20","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1158\/1078-0432.CCR-12-3104","volume":"19","author":"IJG Burvenich","year":"2013","unstructured":"Burvenich IJG, Lee FT, Cartwright GA et al (2013) Molecular imaging of death receptor 5 occupancy and saturation kinetics In Vivo by humanized monoclonal antibody CS-1008. Clin Cancer Res 19:5984\u20135993","journal-title":"Clin Cancer Res"},{"key":"1028_CR21","first-page":"1348","volume":"27","author":"K Hattermann","year":"2012","unstructured":"Hattermann K, Mentlein R, Held-Feindt J (2012) CXCL12 mediates apoptosis resistance in rat C6 glioma cells. Oncol Rep 27:1348\u20131352","journal-title":"Oncol Rep"},{"key":"1028_CR22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/mol.108.053389","volume":"75","author":"I Kalatskaya","year":"2009","unstructured":"Kalatskaya I, Berchiche YA, Gravel S et al (2009) AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75:1240\u20131247","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-016-1028-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-016-1028-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-016-1028-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T14:38:01Z","timestamp":1499265481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-016-1028-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1007\/s11307-016-1028-8","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}